Computerized gait analysis of Botulinum Toxin treatment in children with cerebral palsy

被引:18
|
作者
Galli, Manuela
Cimolin, Veronica
Valente, Enza Maria
Crivellini, Marcello
Ialongo, Tamara
Albertin, Giorgio
机构
[1] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy
[2] IRCCS San Raffaele Pisana, Tosinvest Sanita, Rome, Italy
[3] IRCCS Ist CSS Mendel, Rome, Italy
[4] Univ Cattolica, Ist Neurol, Rome, Italy
[5] San Raffaele Cassino, Tosinvest Sanita, Rome, Italy
关键词
Botulinum Toxin A; cerebral palsy; equinus foot; gait analysis; gastrocnemius;
D O I
10.1080/09638280600948136
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Purpose. Intramuscular botulinum toxin A (BTA) injection is a local reversible treatment with a wide range of therapeutic applications, including temporary reduction of spasticity. The aim of this work was a quantitative, computerized objective evaluation of BTA-induced improvement of the walking functional ability in a group of children with cerebral palsy (CP). Methods. Fifteen children with CP and 20 healthy children were evaluated. All patients were equinus walkers without fixed contractures of triceps surae muscles and they were evaluated before and after about 1.5 months from BTA injections into the calf muscles. The effectiveness of treatment was evaluated by 3D computerized gait analysis. Results. Data analysis revealed a significant improvement of equinus foot and ankle range of motion during gait after BTA injection. Positive effects were evident also at the knee joint as documented by the improvement of kinetics characteristics (moment and power). Conclusions. Computerized gait analysis is a valid method for quantification of BTA effect on walking in children with CP, allowing a detailed evaluation of improvement at each joint and a quantitative evaluation of treatment outcome.
引用
收藏
页码:659 / 664
页数:6
相关论文
共 50 条
  • [41] Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
    Vaile, L.
    Finlay, F.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2006, 91 (10) : 862 - 863
  • [42] Constipation as an adverse event after botulinum toxin A treatment in children with cerebral palsy
    Vles, Georges F.
    Vles, Johan S. H.
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2010, 52 (10): : 972 - 972
  • [43] Adverse events following botulinum toxin type A treatment in children with cerebral palsy
    Langdon, Katherine
    Blair, Eve
    Davidson, Sue-Anne
    Valentine, Jane
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2010, 52 (10): : 972 - 973
  • [44] Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy
    Savarese, R
    Diamond, M
    Elovic, E
    Millis, SR
    [J]. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2004, 83 (04) : 304 - 311
  • [45] Botulinum Toxin for the Treatment of Early-Onset Esotropia in Children With Cerebral Palsy
    Petrushkin, Harry
    Oyewole, Kehinde
    Jain, Saurabh
    [J]. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2012, 49 (02) : 125 - 125
  • [46] Botulinum Toxin A in children with infantile cerebral palsy. Indications and treatment concepts
    Placzek, R.
    [J]. ORTHOPADE, 2010, 39 (01): : 23 - 30
  • [47] Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences
    Lorin, K.
    Forsberg, A.
    [J]. CHILD CARE HEALTH AND DEVELOPMENT, 2016, 42 (04) : 494 - 503
  • [48] Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
    Blumetti, Francesco C.
    Belloti, Joao Carlos
    Tamaoki, Marcel J. S.
    Pinto, Josa A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [49] Botulinum toxin A and cerebral palsy
    Jabbari, B
    Latimer, E
    Clapp, L
    Shrantz, W
    McHale, K
    Coll, D
    [J]. NEUROLOGY, 1998, 50 (04) : A366 - A367
  • [50] Botulinum toxin in cerebral palsy
    Fietzek, U.
    Mall, V.
    [J]. NERVENHEILKUNDE, 2010, 29 (09) : 545 - +